Inovalon Leadership

Dr. Dunleavy has served as Inovalon’s Chief Executive Officer since his organization of the company’s predecessor companies in 1998, as Chairman of the board of directors since the creation of the board in 2006, and as President from the Company’s foundation until May of 2014. Dr. Dunleavy is responsible for the overall execution of the company’s business plan, strategic relationships, and the identification and realization of company product strategy and vision.

During his tenure at Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. Driven by a vision of data’s ability to drive insight and improvement in healthcare, Dr. Dunleavy has led Inovalon from its origins to its current industry-leading position leveraging advanced, cloud-based platforms that are informed by data pertaining to more than 994,000 physicians, 558,000 clinical facilities, 315 million unique patients, and nearly 55 billion medical events providing a powerful platform that enables high-value impact, while improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers.

Dr. Dunleavy received a bachelor’s degree in biology modified with engineering with high honors from Dartmouth College where his studies and work focused upon the neurosciences, computer sciences and electrical engineering with his honors thesis focused on the computer simulation of artificial human cerebellar functional units. Dr. Dunleavy earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, practiced and was Board Certified in Internal Medicine. He serves as a Director on the Dartmouth Medical School Board of Overseers, has authored or co-authored a number of scientific journal articles, abstracts, and proprietary research papers, and has presented his work and materials at multiple national and international conferences.

Ms. Allen serves as Inovalon’s General Counsel, Chief Compliance and Privacy Officer. In this role, Ms. Allen is responsible for the planning, management, execution and oversight of all legal, compliance and privacy matters across the Company and its affiliates. This includes leading the Company’s general corporate matters, intellectual property, compliance, privacy, risk management, regulatory oversight, human resources, audit and investigation, and other transactional matters that implicate legal, compliance and privacy considerations.

Ms. Allen first joined Inovalon in 2016 in the role of Associate Vice President, Associate General Counsel, and was subsequently promoted to Vice President, Deputy General Counsel and Chief Compliance and Privacy Officer. Prior to joining Inovalon in 2016, Ms. Allen was the Chief Integrity Officer at MedStar Washington Hospital Center in Washington, D.C., a nationally recognized healthcare provider. In that capacity, she directed and led the enterprise-wide compliance, privacy, investigative and audit functions. She was also responsible for ensuring overall regulatory and legal compliance, including day-to-day oversight of auditing, monitoring and regulatory compliance activities. Ms. Allen’s previous experience also includes various leadership positions with Booz Allen Hamilton and SRA International where she was responsible for developing and leading legal, compliance, risk management, privacy and information security solutions across the federal and commercial sectors as well as assessing the privacy and security impact and risks associated with new and emerging products and technologies. In addition, Ms. Allen served as a Senior Attorney Advisor for the U.S. Department of Education, District of Columbia Enforcement Office, where she led numerous legal and compliance reviews and a variety of complex investigations. Ms. Allen also served as a Senior Advisor for the Department of Homeland Security where she conceptualized and directed initiatives designed to implement various compliance mandates across the department and its component organizations.

Ms. Allen is a member of the My Sister’s Place, Board of Directors. She is also a Vice-Chair of the Association of Corporate Counsel, Health Law Network.

Ms. Allen received her Bachelor of Arts from the University of Virginia, a Juris Doctor from the University of North Carolina, and a Master of Arts from Georgetown University.

Ingrid E. Olsen is a Chief People Officer at Inovalon.

Mr. Boldt serves as the Chief Financial Officer of Inovalon where he is responsible for the management, planning, implementation and execution of all financial activities, forecasting, reporting, audit, treasury, tax, and related compliance obligations of the Company. Prior to serving in this role, Mr. Boldt served as Vice President of Finance responsible for corporate financial planning and analysis of the Company, and as interim Chief Financial Officer. Since joining the Company in 2012, Mr. Boldt has served in numerous expanding financial positions playing integral roles in the Company’s Initial Public Offering in 2015, the acquisitions of Avalere Health, Inc. in 2015 and Creehan Holding Co. in 2016, and was responsible for the closing of the acquisition of ABILITY Network and its associated term loan financing facility in 2018.

Prior to joining the Company in 2012, Mr. Boldt served in a number of escalating roles at Deloitte & Touche, LLP, ultimately holding the position of attestation manager for public and private, domestic and international clients in information technology, government contracting, professional services, and manufacturing industries at various growth stages and scale ranging from $200 million to $20 billion in annual revenue.

Mr. Boldt graduated magna cum laude from Loyola University in Maryland with a bachelor degree in accounting and a masters of business administration degree with an information technologies concentration. He serves on the Loyola University of Maryland Sellinger School of Business Joint Advisory Board.

Mr. Boldt is an active certified public accountant in the State of Maryland, a status which he has held since 2008.

Ms. Keeneth is a Vice President and serves as the Chief Information Security Officer for Inovalon. In this role, Ms. Keeneth is responsible for managing the Company’s information security risk, security governance, policy, risk management, application security, contingency program, enterprise incident response, cybersecurity, security operations, security tool administration, corporate security, physical security, insider threat, vulnerability management, vendor oversight program and security awareness. Ms. Keeneth leads a team of high performing information security professionals to support Inovalon’s strategic initiatives pertaining to relevant security measures, managing risks, implementing policies and controls, and generating overall awareness. Ms. Keeneth has more than 14 years of experience performing various security advisory and leadership roles.

Prior to joining Inovalon in 2010, Ms. Keeneth served in a number of strategic roles at management consulting firms, DRT Strategies and BearingPoint, supporting clients in federal, regulatory and real estate industries. This experience includes extensive knowledge and application of information security and compliance, security governance, policy, and risk management within the federal government and private sectors.

Ms. Keeneth holds a master’s degree from the University of Virginia in management of information technology and a bachelor’s degree from George Mason University in finance.

Dr. Kilian serves as the Chief Medical Officer (CMO) for Inovalon. In this role, Dr. Kilian is responsible for the oversight of the medical directors of the Company, the clinical content and design of the Company’s software and analytics, and the clinical training, quality, policies, oversight and compliance of associated operations. For more than a decade, Dr. Kilian has led a team of clinical personnel who bring the latest best practices and evidence-based clinical standards to Inovalon’s products and services. Dr. Kilian is well known throughout the healthcare community as an expert on the application of data, software, and analytics to the benefit of clinical protocols, care guidelines, real-world healthcare clinical workflow, and regulatory policy guidelines adherence. Most recently, Dr. Kilian has been recognized with the Healthcare Business Women’s Association 2020 Luminary award.

Prior to joining Inovalon in 2007, Dr. Kilian was in clinical practice with Johns Hopkins Community Physicians, where she served as Medical Director with responsibilities including patient care, clinical training of medical students and residents, and clinical oversight of a multispecialty practice.

Dr. Kilian graduated summa cum laude from Washington and Lee University and earned her doctorate in medicine from Tufts University School of Medicine. She completed her residency in Internal Medicine at The Johns Hopkins Hospital in Baltimore, Maryland.

Peter De Bock is a Chief Administrative Officer (CAO) at Inovalon and is based in Bowie, Maryland. He has worked as Vice President, Regional Controller France-Belgium-The Netherlands-Luxembourg at CA, INC.; Senior auditor at The Estée Lauder Companies Inc.; and Controller Belgium & Luxembourg at CA, INC.. Peter studied at OLVO International between 1974 and 1980, University of Antwerp between 1980 and 1984, and onze lieve vrouwecollege oudenaarde between 1974 and 1980.

Dr. Dunleavy has served as Inovalon’s Chief Executive Officer since his organization of the company’s predecessor companies in 1998, as Chairman of the board of directors since the creation of the board in 2006, and as President from the Company’s foundation until May of 2014. Dr. Dunleavy is responsible for the overall execution of the company’s business plan, strategic relationships, and the identification and realization of company product strategy and vision.

During his tenure at Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. Driven by a vision of data’s ability to drive insight and improvement in healthcare, Dr. Dunleavy has led Inovalon from its origins to its current industry-leading position leveraging advanced, cloud-based platforms that are informed by data pertaining to more than 994,000 physicians, 558,000 clinical facilities, 315 million unique patients, and nearly 55 billion medical events providing a powerful platform that enables high-value impact, while improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers.

Dr. Dunleavy received a bachelor’s degree in biology modified with engineering with high honors from Dartmouth College where his studies and work focused upon the neurosciences, computer sciences and electrical engineering with his honors thesis focused on the computer simulation of artificial human cerebellar functional units. Dr. Dunleavy earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, practiced and was Board Certified in Internal Medicine. He serves as a Director on the Dartmouth Medical School Board of Overseers, has authored or co-authored a number of scientific journal articles, abstracts, and proprietary research papers, and has presented his work and materials at multiple national and international conferences.

Dr. Dunleavy has served as Inovalon’s Chief Executive Officer since his organization of the company’s predecessor companies in 1998, as Chairman of the board of directors since the creation of the board in 2006, and as President from the Company’s foundation until May of 2014. Dr. Dunleavy is responsible for the overall execution of the company’s business plan, strategic relationships, and the identification and realization of company product strategy and vision.

During his tenure at Inovalon, Dr. Dunleavy has worked extensively with a wide array and number of healthcare organizations, regulatory and oversight bodies, and technology companies examining the growing role of data within healthcare, and its ability to drive meaningful insight and improvement for its constituents. Driven by a vision of data’s ability to drive insight and improvement in healthcare, Dr. Dunleavy has led Inovalon from its origins to its current industry-leading position leveraging advanced, cloud-based platforms that are informed by data pertaining to more than 994,000 physicians, 558,000 clinical facilities, 315 million unique patients, and nearly 55 billion medical events providing a powerful platform that enables high-value impact, while improving quality and economics for health plans, ACOs, hospitals, physicians, consumers and pharma/life-sciences researchers.

Dr. Dunleavy received a bachelor’s degree in biology modified with engineering with high honors from Dartmouth College where his studies and work focused upon the neurosciences, computer sciences and electrical engineering with his honors thesis focused on the computer simulation of artificial human cerebellar functional units. Dr. Dunleavy earned his doctorate in medicine from Harvard Medical School, completed his medical residency at The Johns Hopkins Hospital in Baltimore, Maryland, practiced and was Board Certified in Internal Medicine. He serves as a Director on the Dartmouth Medical School Board of Overseers, has authored or co-authored a number of scientific journal articles, abstracts, and proprietary research papers, and has presented his work and materials at multiple national and international conferences.